An EHR-embedded inpatient care pathway for COPD was tied to improved adherence to evidence-based practices, shorter hospital ...
Dr MeiLan Han, of the University of Michigan, Ann Arbor, highlights studies in chronic obstructive pulmonary disease (COPD) presented at the CHEST 2021 Annual Meeting. Dr Han first reports on a study ...
COPD mortality in China decreased from 2014 to 2021, but the disease burden remains high in underdeveloped regions. COPD is mainly caused by air pollution and smoking, with older adults being the most ...
Dr. Rojas-Quintero is researching how Metformin, a long-used diabetes drug, may be able to slow fibrosis in the lungs.
Christopher Carlin, MBChB, PhD, explores the potential of AI-driven insights to enhance COPD care and identify candidates for biologic therapy.
News Medical on MSN
American College of Chest Physicians leads landmark effort to improve access to lifesaving noninvasive ventilation for patients with COPD
CHEST efforts lead to a CMS proposal that includes substantial changes to federal coverage guidelines for NIV devices used in the home.
Inhalers Single-inhaler triple therapy is associated with a favorable benefit-risk profile compared with dual therapy for patients with symptomatic COPD and a history of exacerbations. Single-inhaler ...
Eosinophil Granulocytes COPD Patients with COPD who exhibit low blood eosinophil counts had no change in exacerbations or survival compared with patients with typical counts. Patients with chronic ...
COPD is not reversible; however, it can be controlled. Increased awareness, spirometry testing, and encouraging healthier lifestyles are paramount in reducing the burden of COPD. When detected early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback